相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome
Rachel P. J. Lai et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial
Jonny G. Peter et al.
LANCET (2016)
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
A. Dorothee Heemskerk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis A Systematic Review and Meta-analysis
Olalekan A. Uthman et al.
ANNALS OF INTERNAL MEDICINE (2015)
Value of Urine Lipoarabinomannan Grade and Second Test for Optimizing Clinic-Based Screening for HIV-Associated Pulmonary Tuberculosis
Paul K. Drain et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Treatment of Tuberculosis
C. Robert Horsburgh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding
Taye T. Balcha et al.
GLOBAL HEALTH ACTION (2015)
Effect of physical therapy on muscle strength, respiratory muscles and functional parameters in patients with intensive care unit-acquired weakness
Orna Yosef-Brauner et al.
CLINICAL RESPIRATORY JOURNAL (2015)
Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors
Kocfa Chung-Delgado et al.
PLOS ONE (2015)
Integrating tuberculosis and HIV services in rural Kenya: uptake and outcomes
P. Owiti et al.
PUBLIC HEALTH ACTION (2015)
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
Claudia M. Denkinger et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Double-dose lopinavir-ritonavir in combination with rifampicin-based anti-tuberculosis treatment in South Africa
H. Sunpath et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE: Timing, Severity, and Implications for HIV-TB Programs
Anne F. Luetkemeyer et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial
Sayoki G. Mfinanga et al.
LANCET INFECTIOUS DISEASES (2014)
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Beatriz Grinsztejn et al.
LANCET INFECTIOUS DISEASES (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV-infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy
Suhashni Naiker et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Impact of Pharmacogenetic Markers of CYP2B6, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients
Weerawat Manosuthi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Frequency, Severity, and Prediction of Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome
Suzaan Marais et al.
CLINICAL INFECTIOUS DISEASES (2013)
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial
Maryline Bonnet et al.
LANCET INFECTIOUS DISEASES (2013)
CURRENT CONCEPTS Tuberculosis
Alimuddin Zumla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis
Helen van der Plas et al.
PLOS ONE (2013)
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV Patients with Culture Confirmed Pulmonary Tuberculosis in India and the Potential Role of IL-6 in Prediction
Gopalan Narendran et al.
PLOS ONE (2013)
Incidence of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Impact on Patient Outcome
Maryline Bonnet et al.
PLOS ONE (2013)
Tuberculosis and HIV Coinfection Preface
Jacob M. Gray et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review
Helena Legido-Quigley et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection
William Worodria et al.
ANTIVIRAL THERAPY (2012)
An Updated Systematic Review and Meta-analysis on the Treatment of Active Tuberculosis in Patients With HIV Infection
Faiz Ahmad Khan et al.
CLINICAL INFECTIOUS DISEASES (2012)
Rapid Diagnosis of Tuberculosis in Aspirate, Effusions, and Cerebrospinal Fluid by Immunocytochemical Detection of Mycobacterium tuberculosis Complex Specific Antigen MPT64
Manju Raj Purohit et al.
DIAGNOSTIC CYTOPATHOLOGY (2012)
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis
Tanuja N. Gengiah et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future
Rannakoe J. Lehloenya et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
The chemotherapy of tuberculosis: past, present and future
D. Mitchison et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Time to Initiate Antiretroviral Therapy Between 4 Weeks and 12 Weeks of Tuberculosis Treatment in HIV-Infected Patients: Results From the TIME Study
Weerawat Manosuthi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Modest but Variable Effect of Rifampin on Steady-State Plasma Pharmacokinetics of Efavirenz in Healthy African-American and Caucasian Volunteers
Awewura Kwara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township
Stephen D. Lawn et al.
BMC INFECTIOUS DISEASES (2011)
Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
M. Estee Toeroek et al.
CLINICAL INFECTIOUS DISEASES (2011)
Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs
Thomas N. Kakuda et al.
CLINICAL PHARMACOKINETICS (2011)
British HIV Association guidelines for the treatment of TB/HIV coinfection 2011
A. L. Pozniak et al.
HIV MEDICINE (2011)
Integration of Antiretroviral Therapy with Tuberculosis Treatment
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
Francois-Xavier Blanc et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study
Lesley E. Scott et al.
PLOS MEDICINE (2011)
Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment-Induced Hepatotoxicity
Surendra K. Sharma et al.
CLINICAL INFECTIOUS DISEASES (2010)
Treatment of Active Tuberculosis in HIV-Coinfected Patients: A Systematic Review and Meta-Analysis
Faiz A. Khan et al.
CLINICAL INFECTIOUS DISEASES (2010)
Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study
Weerawat Manosuthi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
Monika Müller et al.
LANCET INFECTIOUS DISEASES (2010)
An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV
Kevin P. Cain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples
Keertan Dheda et al.
PLOS ONE (2010)
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults
Sumonmal Uttayamakul et al.
AIDS RESEARCH AND THERAPY (2010)
Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages
Stephen D. Lawn et al.
AIDS (2009)
Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
Weerawat Manosuthi et al.
AIDS (2009)
Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir
Larissa A. Wenning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database
Jialun Zhou et al.
BMC INFECTIOUS DISEASES (2009)
A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse-Transcriptase Inhibitor-Based Regimens in HIV-Infected Patients Receiving Rifampicin: The N2R Study
Weerawat Manosuthi et al.
CLINICAL INFECTIOUS DISEASES (2009)
Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs
D. J. B. Marks et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2009)
Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir
David W. Haas et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings
Michael J. A. Reid et al.
LANCET INFECTIOUS DISEASES (2009)
Immune reconstitution and Unmasking of tuberculosis during antiretroviral therapy
Stephen D. Lawn et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin
W. Manosuthi et al.
HIV MEDICINE (2008)
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy
Andrew Boulle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
Graeme Meintjes et al.
LANCET INFECTIOUS DISEASES (2008)
Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients
Getnet Yimer et al.
PLOS ONE (2008)
Hepatic involvement with tuberculosis-associated immune reconstitution disease
Stephen D. Lawn et al.
AIDS (2007)
Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting
Weerawat Manosuthi et al.
JOURNAL OF INFECTION (2007)
Metabolism and disposition in humans of raltegravir (MK-0518), an Anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme
Kelem Kassahun et al.
DRUG METABOLISM AND DISPOSITION (2007)
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily
Edward P. Acosta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Immunohistochemical diagnosis of abdominal and lymph node tuberculosis by detecting Mycobacterium tuberculosis complex specific antigen MPT64
Manju R. Purohit et al.
DIAGNOSTIC PATHOLOGY (2007)
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
J. Dinnes et al.
HEALTH TECHNOLOGY ASSESSMENT (2007)
Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy
Weerawat Manosuthi et al.
JOURNAL OF INFECTION (2006)
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review
Karen R. Steingart et al.
LANCET INFECTIOUS DISEASES (2006)
Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers
D. M. Burger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy
Weerawat Manosuthi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Immune reconstitution syndrome in HIV: Validating a case definition and identifying clinical predictors in persons initiating Antiretroviral therapy
J Robertson et al.
CLINICAL INFECTIOUS DISEASES (2006)
Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand
S Sungkanuparph et al.
JOURNAL OF INFECTION (2006)
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients
A Bourgarit et al.
AIDS (2006)
Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results
W Manosuthi et al.
AIDS (2006)
Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005
L John et al.
AIDS (2005)
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin
W Manosuthi et al.
AIDS (2005)
Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?
RAM Breen et al.
AIDS (2005)
Clinical and radiographic correlates of primary and reactivation tuberculosis - A molecular epidemiology study
E Geng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Tuberculosis in HIV-infected patients:: a comprehensive review
L Aaron et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Immune restoration disease after antiretroviral therapy
MA French et al.
AIDS (2004)
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection
RAM Breen et al.
THORAX (2004)
Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial
A Jindani et al.
LANCET (2004)
Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis
S Sungkanuparph et al.
AIDS (2003)
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis
D Yee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Modern laboratory diagnosis of tuberculosis
FA Drobniewski et al.
LANCET INFECTIOUS DISEASES (2003)
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
YD Mukadi et al.
AIDS (2001)
分享论文
